{"title":"透析前和透析患者血清磷酸盐水平与死亡率的关系","authors":"Aiyoub Pezeshgi, Yasaman Alemohammad, Arian Tavasol, Hamed Hajishah, Maryam Ghasemi, Mahsa Sayadizadeh, Sajad Raeisi Estabragh, Mojtaba Haddad, Soheila Mahdavynia, Mehdi Noormohammad","doi":"10.25259/ijn_398_23","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Discovering predictors to reduce morbidity and mortality in chronic kidney disease (CKD) is now a critical global priority. Serum phosphate level is considered to be a potential marker for mortality rate in patients with CKD. Previous studies examined the independent pathogenic role of phosphorus in the development of CKD and dialysis patients but have yielded contradictory findings. This study aims at evaluating the relationship between serum phosphate levels and death rates in pre-dialysis CKD and maintenance of dialysis patients.</p><p><strong>Materials and methods: </strong>PubMed, Scopus, and Web of Science were searched by using MeSH term keywords. The authors did screening, data extraction, and quality assessment in accordance with the inclusion criteria. STATA 14.2 was used for statistical analyses. The analysis was performed using the random- and fixed-effects model when the heterogeneity was >50% and ≤50%, respectively. For evaluating publication bias, Funnel plots and Egger tests were used.</p><p><strong>Results: </strong>Eleven original studies between 2005 and 2021 met the eligibility criteria. The overall estimate of unadjusted HR of all-cause mortality each 1 mg/dL increase in the serum phosphate concentration using the random-effects model in pre-dialysis CKD and dialysis patients was 1.33 (95% CI: 0.97, 1.82, I<sup>2</sup> = 99.1%, P = 0.074), and for adjustment, Hazard ratio was 1.27 (95% CI: 1.15, 1.39, I<sup>2</sup> = 75.4%, P < 0.001).</p><p><strong>Conclusion: </strong>The findings showed the association between serum phosphate levels and death rates in pre-dialysis individuals with CKD and dialysis patients.</p>","PeriodicalId":13359,"journal":{"name":"Indian Journal of Nephrology","volume":"35 4","pages":"485-489"},"PeriodicalIF":0.8000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12395094/pdf/","citationCount":"0","resultStr":"{\"title\":\"The Association Between the Levels of Serum Phosphate and Mortality Rates in Pre-Dialysis and Dialysis Patients.\",\"authors\":\"Aiyoub Pezeshgi, Yasaman Alemohammad, Arian Tavasol, Hamed Hajishah, Maryam Ghasemi, Mahsa Sayadizadeh, Sajad Raeisi Estabragh, Mojtaba Haddad, Soheila Mahdavynia, Mehdi Noormohammad\",\"doi\":\"10.25259/ijn_398_23\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Discovering predictors to reduce morbidity and mortality in chronic kidney disease (CKD) is now a critical global priority. Serum phosphate level is considered to be a potential marker for mortality rate in patients with CKD. Previous studies examined the independent pathogenic role of phosphorus in the development of CKD and dialysis patients but have yielded contradictory findings. This study aims at evaluating the relationship between serum phosphate levels and death rates in pre-dialysis CKD and maintenance of dialysis patients.</p><p><strong>Materials and methods: </strong>PubMed, Scopus, and Web of Science were searched by using MeSH term keywords. The authors did screening, data extraction, and quality assessment in accordance with the inclusion criteria. STATA 14.2 was used for statistical analyses. The analysis was performed using the random- and fixed-effects model when the heterogeneity was >50% and ≤50%, respectively. For evaluating publication bias, Funnel plots and Egger tests were used.</p><p><strong>Results: </strong>Eleven original studies between 2005 and 2021 met the eligibility criteria. The overall estimate of unadjusted HR of all-cause mortality each 1 mg/dL increase in the serum phosphate concentration using the random-effects model in pre-dialysis CKD and dialysis patients was 1.33 (95% CI: 0.97, 1.82, I<sup>2</sup> = 99.1%, P = 0.074), and for adjustment, Hazard ratio was 1.27 (95% CI: 1.15, 1.39, I<sup>2</sup> = 75.4%, P < 0.001).</p><p><strong>Conclusion: </strong>The findings showed the association between serum phosphate levels and death rates in pre-dialysis individuals with CKD and dialysis patients.</p>\",\"PeriodicalId\":13359,\"journal\":{\"name\":\"Indian Journal of Nephrology\",\"volume\":\"35 4\",\"pages\":\"485-489\"},\"PeriodicalIF\":0.8000,\"publicationDate\":\"2025-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12395094/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Indian Journal of Nephrology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.25259/ijn_398_23\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/8/29 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q4\",\"JCRName\":\"UROLOGY & NEPHROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Indian Journal of Nephrology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.25259/ijn_398_23","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/8/29 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0
摘要
背景:发现降低慢性肾脏疾病(CKD)发病率和死亡率的预测因子是目前全球的一个关键优先事项。血清磷酸盐水平被认为是CKD患者死亡率的潜在标志。先前的研究考察了磷在CKD和透析患者发展中的独立致病作用,但得出了相互矛盾的结果。本研究旨在评估透析前CKD患者血清磷酸盐水平与死亡率及透析维持的关系。材料与方法:采用MeSH关键词检索PubMed、Scopus、Web of Science。作者按照纳入标准进行筛选、资料提取和质量评价。采用STATA 14.2进行统计分析。异质性分别为bbb50 %和≤50%时,采用随机效应模型和固定效应模型进行分析。评价发表偏倚采用漏斗图和Egger检验。结果:2005年至2021年间的11项原始研究符合资格标准。使用随机效应模型,在透析前CKD和透析患者中,血清磷酸盐浓度每增加1 mg/dL,未校正的全因死亡率总风险比为1.33 (95% CI: 0.97, 1.82, I2 = 99.1%, P = 0.074),校正后的风险比为1.27 (95% CI: 1.15, 1.39, I2 = 75.4%, P < 0.001)。结论:研究结果显示透析前CKD患者和透析患者的血清磷酸盐水平与死亡率之间存在相关性。
The Association Between the Levels of Serum Phosphate and Mortality Rates in Pre-Dialysis and Dialysis Patients.
Background: Discovering predictors to reduce morbidity and mortality in chronic kidney disease (CKD) is now a critical global priority. Serum phosphate level is considered to be a potential marker for mortality rate in patients with CKD. Previous studies examined the independent pathogenic role of phosphorus in the development of CKD and dialysis patients but have yielded contradictory findings. This study aims at evaluating the relationship between serum phosphate levels and death rates in pre-dialysis CKD and maintenance of dialysis patients.
Materials and methods: PubMed, Scopus, and Web of Science were searched by using MeSH term keywords. The authors did screening, data extraction, and quality assessment in accordance with the inclusion criteria. STATA 14.2 was used for statistical analyses. The analysis was performed using the random- and fixed-effects model when the heterogeneity was >50% and ≤50%, respectively. For evaluating publication bias, Funnel plots and Egger tests were used.
Results: Eleven original studies between 2005 and 2021 met the eligibility criteria. The overall estimate of unadjusted HR of all-cause mortality each 1 mg/dL increase in the serum phosphate concentration using the random-effects model in pre-dialysis CKD and dialysis patients was 1.33 (95% CI: 0.97, 1.82, I2 = 99.1%, P = 0.074), and for adjustment, Hazard ratio was 1.27 (95% CI: 1.15, 1.39, I2 = 75.4%, P < 0.001).
Conclusion: The findings showed the association between serum phosphate levels and death rates in pre-dialysis individuals with CKD and dialysis patients.